Indegene P/E Ratio

INDGN • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
25.5
High Valuation
High - Growth expectations or overvalued

Current Valuation Metrics

P/E Ratio 25.5
Current Price ₹483.15
EPS (TTM) ₹17.15
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 33.87
Historical Range 33.12 - 34.62
Percentile 0.0%

Sector Context

Sector Average 47.65
Sector Median 25.75
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹18.32
Sept 2025 ₹4.26
Mar 2025 ₹4.91

Key P/E Ratio Insights for Indegene

  • Stock appears overvalued with PE of 25.5, suggesting caution for new investments
  • Current PE is 24.7% below historical average
  • Trading at discount to sector average PE of 47.65

P/E Ratio Historical Trend for Indegene

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 33.12 18.32 ₹606.80 NSE High
2024 34.62 16.49 ₹570.90 NSE High

Sector P/E Ratio Comparison

Comparing Indegene with other companies in Healthcare sector
Sector Average
47.65
Sector Median
25.75
Lowest P/E
0.83
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.83 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.53 ₹1,133 Low
Amwill Health Care AMWILL 5.67 ₹64 Low
Brooks Laboratories BROOKS 6.14 ₹157 Low
Medicamen Organics MEDIORG 6.4 ₹27 Low
Zenith Drugs ZENITHDRUG 6.83 ₹69 Low
Unichem Laboratories UNICHEMLAB 7.15 ₹2,100 Low
Galaxy Medicare GML 7.41 ₹26 Low
Vasundhara Rasayans VRL 9.35 ₹34 Low